医薬品受託開発製造機関(CDMO)アウトソーシングの世界市場2021年-2025年

◆英語タイトル:Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market 2021-2025
◆商品コード:IRTNTR43489
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年5月31日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は、医薬品受託開発製造機関(CDMO)アウトソーシングの世界市場規模が2021年から2025年まで年平均11%以上成長し、644.4億ドルに達すると予測しています。本調査レポートでは世界の医薬品受託開発製造機関(CDMO)アウトソーシング市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(小分子、生物製剤)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の項目でまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・医薬品受託開発製造機関(CDMO)アウトソーシングの世界市場規模:製品別(小分子、生物製剤)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market 2021-2025

Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by $ 64.44 bn during 2021-2025, progressing at a CAGR of over 11% during the forecast period. Our report on contract development and manufacturing organization (CDMO) outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing pharmaceutical industry and increasing demand for one-stop-shop CDMOs. In addition, growing pharmaceutical industry is anticipated to boost the growth of the market as well.

The contract development and manufacturing organization (CDMO) outsourcing market analysis includes product segment and geographic landscape.
Technavio’s contract development and manufacturing organization (CDMO) outsourcing market is segmented as below:

By Product
• Small molecules
• Biologics

By Geographical Landscape
• North America
• Europe
• APAC
• South America
• MEA

This study identifies the support of CDMO in reducing operational and capital expenses as one of the prime reasons driving the contract development and manufacturing organization (CDMO) outsourcing market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on contract development and manufacturing organization (CDMO) outsourcing market covers the following areas:
• Contract development and manufacturing organization (CDMO) outsourcing market sizing
• Contract development and manufacturing organization (CDMO) outsourcing market forecast
• Contract development and manufacturing organization (CDMO) outsourcing market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract development and manufacturing organization (CDMO) outsourcing market vendors that include Almac Group Ltd., Apollo 5 GmbH, Catalent Inc., FAMAR Health Care Services, FUJIFILM Holdings Corp., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., and Thermo Fisher Scientific Inc. Also, the contract development and manufacturing organization (CDMO) outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/contract-development-and-manufacturing-organization-outsourcing-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Small molecules – Market size and forecast 2020-2025
o Biologics – Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o APAC – Market size and forecast 2020-2025
o South America – Market size and forecast 2020-2025
o MEA – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Almac Group Ltd.
o Apollo 5 GmbH
o Catalent Inc.
o FAMAR Health Care Services
o FUJIFILM Holdings Corp.
o Lonza Group Ltd.
o Recipharm AB
o Siegfried Holding AG
o The Lubrizol Corp.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ billion)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Product – Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Small molecules – Market size and forecast 2020-2025 ($ billion)
• 24: Small molecules – Year-over-year growth 2020-2025 (%)
• 25: Biologics – Market size and forecast 2020-2025 ($ billion)
• 26: Biologics – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ billion)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ billion)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: APAC – Market size and forecast 2020-2025 ($ billion)
• 36: APAC – Year-over-year growth 2020-2025 (%)
• 37: South America – Market size and forecast 2020-2025 ($ billion)
• 38: South America – Year-over-year growth 2020-2025 (%)
• 39: MEA – Market size and forecast 2020-2025 ($ billion)
• 40: MEA – Year-over-year growth 2020-2025 (%)
• 41: Key leading countries
• 42: Market opportunity By Geographical Landscape ($ billion)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Almac Group Ltd. – Overview
• 50: Almac Group Ltd. – Product and service
• 51: Almac Group Ltd. – Key offerings
• 52: Almac Group Ltd. – Key customers
• 53: Almac Group Ltd. – Segment focus
• 54: Apollo 5 GmbH – Overview
• 55: Apollo 5 GmbH – Business segments
• 56: Apollo 5 GmbH – Key offerings
• 57: Apollo 5 GmbH – Key customers
• 58: Apollo 5 GmbH – Segment focus
• 59: Catalent Inc. – Overview
• 60: Catalent Inc. – Business segments
• 61: Catalent Inc. – Key offerings
• 62: Catalent Inc. – Key customers
• 63: Catalent Inc. – Segment focus
• 64: FAMAR Health Care Services – Overview
• 65: FAMAR Health Care Services – Product and service
• 66: FAMAR Health Care Services – Key offerings
• 67: FAMAR Health Care Services – Key customers
• 68: FAMAR Health Care Services – Segment focus
• 69: FUJIFILM Holdings Corp. – Overview
• 70: FUJIFILM Holdings Corp. – Business segments
• 71: FUJIFILM Holdings Corp. – Key offerings
• 72: FUJIFILM Holdings Corp. – Key customers
• 73: FUJIFILM Holdings Corp. – Segment focus
• 74: Lonza Group Ltd. – Overview
• 75: Lonza Group Ltd. – Business segments
• 76: Lonza Group Ltd. – Key offerings
• 77: Lonza Group Ltd. – Key customers
• 78: Lonza Group Ltd. – Segment focus
• 79: Recipharm AB – Overview
• 80: Recipharm AB – Business segments
• 81: Recipharm AB – Key offerings
• 82: Recipharm AB – Key customers
• 83: Recipharm AB – Segment focus
• 84: Siegfried Holding AG – Overview
• 85: Siegfried Holding AG – Business segments
• 86: Siegfried Holding AG – Key offerings
• 87: Siegfried Holding AG – Key customers
• 88: Siegfried Holding AG – Segment focus
• 89: The Lubrizol Corp. – Overview
• 90: The Lubrizol Corp. – Product and service
• 91: The Lubrizol Corp. – Key offerings
• 92: The Lubrizol Corp. – Key customers
• 93: The Lubrizol Corp. – Segment focus
• 94: Thermo Fisher Scientific Inc. – Overview
• 95: Thermo Fisher Scientific Inc. – Business segments
• 96: Thermo Fisher Scientific Inc. – Key offerings
• 97: Thermo Fisher Scientific Inc. – Key customers
• 98: Thermo Fisher Scientific Inc. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

Almac Group Ltd., Apollo 5 GmbH, Catalent Inc., FAMAR Health Care Services, FUJIFILM Holdings Corp., Lonza Group Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医薬品受託開発製造機関(CDMO)アウトソーシングの世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆